论文部分内容阅读
目的:探讨联合应用降压药治疗2型糖尿病合并高血压临床疗效。方法:采取随机分组平行分组对照方法,将患者分为两组,A组29例,单用硝苯地平缓释片40 mg/d;B组29例,硝苯地平缓释片20 mg/d+缬沙坦(血管紧张素Ⅱ受体阻滞剂,ARB)80 mg/d。结果:治疗8周后,B组收缩压(SBP)<130 mm Hg和舒张压(DBP)<80 mm Hg,达标率分别为68.96%和93.10%,较A组明显增高(P<0.05),不良反应少(P<0.05)。结论:钙拮抗剂联合ARB治疗2型糖尿病合并高血压疗效理想,且不良反应低。
Objective: To investigate the clinical effect of combined antihypertensive drugs on type 2 diabetes with hypertension. Methods: A randomized controlled group was divided into two groups: group A (n = 29), nifedipine 40 mg / d alone, group B (n = 29), nifedipine 20 mg / Valsartan (angiotensin II receptor blocker, ARB) 80 mg / d. Results: After 8 weeks of treatment, systolic blood pressure (SBP) <130 mm Hg and DBP <80 mm Hg in group B were significantly higher than those in group A (68.96% and 93.10%, respectively) Adverse reactions were less (P <0.05). Conclusion: Calcium antagonist combined with ARB is effective in treating type 2 diabetes mellitus complicated with hypertension and its adverse reaction is low.